Pre-Clinical Lessons We Wish We’d Known

Resources

Pre-Clinical Lessons We Wish We’d Known

What seasoned medtech developers would do differently — and why it matters

Pre-clinical studies and early-stage trials are some of the most challenging — and expensive — milestones in medical device development. Yet, many teams encounter avoidable setbacks that could have been prevented with strategic foresight and practical lessons learned from experience.

In the webinar “Pre-Clinical Lessons We Wish We’d Known,” three experienced medtech professionals — Joris van der Heijden (Concept Development Lead), Paul Hulme (Human Factors Engineer), and Nick Allan (Bio Services Manager) from StarFish Medical — share candid stories, real-world challenges, and the pivotal pre-clinical insights they’ve gained over decades of medical device development.

Key Takeaways from the Webinar:

  • Design with the drug container in mind — Why selecting or accommodating the right primary drug container is critical for pharma partnerships and market acceptance.
  • Minimizing use errors through user-centered design — How real-world user behavior and stress conditions impact device performance, and why early usability testing is essential.
  • Lessons in IFU reliance and training — Why you can’t count on users reading instructions, and how hands-on training and competency checks can mitigate risk.
  • Packaging and labeling pitfalls — Surprising findings on what users actually notice on packaging (and what they don’t) and how simple design changes can improve safety and compliance.
  • The risks of last-minute design changes before trials — A cautionary story from clinical research where small hardware adjustments led to major setbacks.
  • Pre-clinical validation strategies that work — How simulation models, imaging studies, and stepwise testing can reduce uncertainty before entering costly clinical trials.

Whether you’re an engineer, program manager, clinical lead, or regulatory professional, this webinar offers practical, hard-earned advice to help you avoid delays, reduce risk, and position your medical device for clinical and market success.

Speakers

  • Joris van der Heijden, Concept Development Lead, StarFish Medical
  • Paul Hulme, Human Factors Engineer, StarFish Medical
  • Nick Allan, Bio Services Manager, StarFish Medical

Pre-Clinical Lessons We Wish We’d Known

Insights to help you avoid costly mistakes — before clinical trials begin.

Watch the recording
Nick and Nigel each holding a different USPTO patent certificate, illustrating the difference between a design patent and a utility patent in a Bio Break episode

Design Patent vs Utility Patent: What’s the Difference?

In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.

Mickey Urdea and Scott Phillips headshots for MedTech Unscripted exit strategy webinar

Built for Exit: What Drives MedTech Success

Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.

Gloved technician handling sterile medical device packages during V&V sample testing

MD+DI: Medical Device V&V Cost and Timeline Explained

Nigel Syrotuck breaks down the realistic medical device V&V cost and schedule for terminally sterilized devices, picking up after design freeze and walking through each major phase of the process.

Palletized medical device shipments in warehouse facility illustrating sterilization supply chain costs.

MD+DI: Hidden Costs of Medical Device Sterilization

Nigel Syrotuck examines the hidden medical device sterilization costs that many development teams overlook when estimating the true cost of producing a terminally sterilized device.